Insiders Trades

★ Sign in to follow

DJ

Doug Janzen

Aequus Pharmaceuticals Inc.

Cumul. flow

Total declarations

42

Company

1

▲ Purchases (38 ops.)

€271k

▼ Sales (1 ops.)

—

Latest filing published 30 Nov 2022 for Aequus Pharmaceuticals Inc., €2,499.

Filing timeline

BuySale

Doug Janzen

Insider track record

Disclosed buys

38

Disclosed sells

1

Signal history

Doug Janzen: trading record in brief

Doug Janzen appears in our data through filings on Aequus Pharmaceuticals Inc. shares, published by SEDI. Between 16 February 2016 and 30 November 2022, the trades on record add up to 42 filings.

Market trades split into 38 purchases (€271k) and 1 sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 option exercise. So far in 2022, the count stands at 5 purchases and 1 sale.

A typical purchase (the median) is worth €3,388. The 30 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The latest filing, published on 30 November 2022, reports an open-market purchase of €2,499 in Aequus Pharmaceuticals Inc. Filings reach the SEDI feed a median of 1 day after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Doug Janzen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Aequus Pharmaceuticals Inc. (CA)

Declarations42 total

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives20 Nov 2022Aequus Pharmaceuticals Inc.

3,450 CAD11SEDI

115,000 shares@ CA$0.030.5% of flowCommon SharesTSXSEDI:4035647

Canonical exit: 18 Feb 2023 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives30 Nov 2022Aequus Pharmaceuticals Inc.

11,400 CAD0SEDI

285,000 shares@ CA$0.04Common SharesTSXSEDI:4035648

Canonical exit: 28 Feb 2023 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives20 Jul 2022Aequus Pharmaceuticals Inc.

7,500 CAD0SEDI

100,000 shares@ CA$0.075Common SharesTSXSEDI:3979932

Canonical exit: 18 Oct 2022 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives19 Jul 2022Aequus Pharmaceuticals Inc.

80 CAD0SEDI

1,000 shares@ CA$0.08Common SharesTSXSEDI:3979597

Canonical exit: 17 Oct 2022 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives19 Jul 2022Aequus Pharmaceuticals Inc.

6,930 CAD0SEDI

99,000 shares@ CA$0.07Common SharesTSXSEDI:3979595

Canonical exit: 17 Oct 2022 (T+90)

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Apr 2022Aequus Pharmaceuticals Inc.

0SEDI

5,000 sharesCommon SharesTSXSEDI:3920931

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Sept 2021Aequus Pharmaceuticals Inc.

72,500 CAD18SEDI

500,000 shares@ CA$0.14511.2% of flowCommon SharesTSXSEDI:3796864

Canonical exit: 30 Nov 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives2 Jun 2021Aequus Pharmaceuticals Inc.

31,720 CAD17SEDI

200,000 shares@ CA$0.15865.0% of flowCommon SharesTSXSEDI:3755244

Canonical exit: 31 Aug 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives27 Apr 2021Aequus Pharmaceuticals Inc.

185 CAD11SEDI

1,000 shares@ CA$0.1850.0% of flowCommon SharesTSXSEDI:3734747

Canonical exit: 26 Jul 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives27 Apr 2021Aequus Pharmaceuticals Inc.

35,055 CAD12SEDI

184,500 shares@ CA$0.195.4% of flowCommon SharesTSXSEDI:3734779

Canonical exit: 26 Jul 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives27 Apr 2021Aequus Pharmaceuticals Inc.

14,900 CAD11SEDI

74,500 shares@ CA$0.202.3% of flowCommon SharesTSXSEDI:3734784

Canonical exit: 26 Jul 2021 (T+90)

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Apr 2021Aequus Pharmaceuticals Inc.

187,500 CAD14SEDI

1,562,500 shares@ CA$0.1229.3% of flowCommon SharesTSXSEDI:3722100

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Jan 2021Aequus Pharmaceuticals Inc.

15,600 CAD11SEDI

130,000 shares@ CA$0.122.2% of flowCommon SharesTSXSEDI:3664724

Canonical exit: 15 Apr 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Jan 2021Aequus Pharmaceuticals Inc.

8,750 CAD11SEDI

70,000 shares@ CA$0.1251.2% of flowCommon SharesTSXSEDI:3664725

Canonical exit: 15 Apr 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives8 Dec 2020Aequus Pharmaceuticals Inc.

20,600 CAD0SEDI

200,000 shares@ CA$0.103Common SharesTSXSEDI:3639001

Canonical exit: 8 Mar 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Dec 2020Aequus Pharmaceuticals Inc.

16,200 CAD0SEDI

150,000 shares@ CA$0.108Common SharesTSXSEDI:3634944

Canonical exit: 1 Mar 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives30 Oct 2020Aequus Pharmaceuticals Inc.

2,688 CAD0SEDI

21,500 shares@ CA$0.125Common SharesTSXSEDI:3620748

Canonical exit: 28 Jan 2021 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives20 Oct 2020Aequus Pharmaceuticals Inc.

15,150 CAD0SEDI

150,000 shares@ CA$0.101Common SharesTSXSEDI:3617035

Canonical exit: 18 Jan 2021 (T+90)

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives6 Aug 2020Aequus Pharmaceuticals Inc.

250,000 CAD19SEDI

3,125,000 shares@ CA$0.0823.6% of flowCommon SharesTSXSEDI:3586345

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives8 Jun 2020Aequus Pharmaceuticals Inc.

8,000 CAD11SEDI

100,000 shares@ CA$0.080.8% of flowCommon SharesTSXSEDI:3561650

Canonical exit: 6 Sept 2020 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives9 Jun 2020Aequus Pharmaceuticals Inc.

3,910 CAD13SEDI

46,000 shares@ CA$0.0850.4% of flowCommon SharesTSXSEDI:3561660

Canonical exit: 7 Sept 2020 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives9 Jun 2020Aequus Pharmaceuticals Inc.

4,320 CAD13SEDI

54,000 shares@ CA$0.080.4% of flowCommon SharesTSXSEDI:3561655

Canonical exit: 7 Sept 2020 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives18 Sept 2017Aequus Pharmaceuticals Inc.

47,770 CAD18SEDI

281,000 shares@ CA$0.176.5% of flowCommon SharesTSXSEDI:3060884

Canonical exit: 17 Dec 2017 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives18 Sept 2017Aequus Pharmaceuticals Inc.

3,040 CAD17SEDI

19,000 shares@ CA$0.160.4% of flowCommon SharesTSXSEDI:3060885

Canonical exit: 17 Dec 2017 (T+90)

▲

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Sept 2017Aequus Pharmaceuticals Inc.

4,125 CAD17SEDI

25,000 shares@ CA$0.1650.6% of flowCommon SharesTSXSEDI:3057867

Canonical exit: 11 Dec 2017 (T+90)

25 of 42 declarations